ARWR R&D Expense Growth
Arrowhead Pharmaceuticals Inc · R&D Expense Growth
ARWR R&D Expense Growth
Latest reported24.11%period ending
ARWR FY R&D Growth (YoY) (0.00% → 24.11%)
Latest values, visible window
High-resolution chart · PNG
ARWR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 24.1086% | |
| 42.9152% | |
| 18.6523% | |
| 39.8164% | |
| 67.0194% | |
| 61.2242% | |
| 58.6636% | |
| 4.4197% | |
| 11.5731% | |
| -12.2979% | |
| 104.2841% | |
| 165.7827% | |
| 61.4706% | |
| 64.4862% | |
| 282.2866% | |
| -86.1868% | |
| -25.301% | |
| -24.014% | |
| 27.4251% | |
| 126.2369% | |
| 378.1443% | |
| 23,406.7852% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |